Healthcare
Retatrutide obesity jab sheds a quarter of body weight
The experimental obesity drug retatrutide helped adults with type 2 diabetes lose up to a quarter of their body weight in a landmark phase 3 trial.
The experimental obesity drug retatrutide helped adults with type 2 diabetes lose up to a quarter of their body weight in a landmark phase 3 trial.